What CNS Summit Attendees Say

Participant Testimonials

“It’s different. I’ve never seen anything close to the content I’ve seen today and it gave me lots of new ideas. It’s a very nice collaborative setting.”

David V. Sheehan MD MBA, Distinguished University Health Professor Emeritus, University of South Florida College of Medicine

“What I like is that it’s a pre-competitive space where we can come in and talk about issues that a lot of people don’t want to talk about. What’s going wrong with the trials and how can we do better. “There’s not a lot of fluff. People who really care are at the CNS Summit.”

Steve Brannan, VP and Therapeutic Area Leader for Neuroscience, Clinical Development , Clinical Science at Takeda Pharmaceuticals

“The emphasis here is on finding the practical solution. If you have any interest in meeting the challenges that we face in developments for CNS disorders, you ought to come here. You are going to find something of interest to you.”

Gary Sachs, M.D., Therapeutic Area Leader, Bracket

"If you are doing any kind of CNS research – whether you're a sponsor, a CRO, or an investigator – you should be here."

Thomas Zoda, Senior Vice President, Clinical Development, Neurology and Psychiatry, INC Research

“In addition to the open-minded attitude, is that we have decision-makers here that can make it happen. We can put these things into action rather than just verbalize them.”

Chuck Wilcox, Executive Director, Pharmacology Research Institute (PRI)

“The CNS Summit is very innovative and forward-thinking. It’s a fun environment and it’s an environment that shows us what the future might look and how we can all work together to pull ourselves up and do a better job. Anybody who cares about psychiatric or neurologic drug development, you should be here.”

Dr. Andrew Cutler, CEO and CMO of Florida Clinical Research Center

“Every sector is at the table at the CNS Summit, and they are all working actively to solve our challenges. I particularly like the emphasis on putting the patients' interests first.”

Bonnie Segal, Vice President, Segal Institute for Clinical Research

“As a direct result of my attendance at CNS Summit, I was offered a great contract with a new client. If, as an independent monitoring consultant, CNS is your chosen therapeutic area, I’d highly recommend attending this meeting.”

Rosemary Chang, Research Compliance Consulting Services, Inc., Independent Clinical Research Consultant

“It’s an opportunity for us to get together with the people that we work with on a regular basis to talk about some of the problems that we face and come up with solutions to those problems.”

David Walling, PhD, Chief Executive and Clinical Officer at Collaborative Neuroscience Network, Inc.